Contact Us

Please leave a message

×

Boosting Taiwan’s Contract Research and Manufacturing Outsourcing Sector to Meet Growing Demand Listen with ReadSpeaker

The COVID-19 pandemic has driven global pharmaceutical companies to reevaluate and transform their supply chain processes. One increasingly preferred approach is by outsourcing research and manufacturing to external service providers, to reduce costs and maximize manufacturing scalability.

In recent years, Taiwan has gained a strong reputation for its successful Contract Research Outsourcing, Contract Development and Manufacturing Outsourcing (CRO/CDMO) sector. Two of DKSH’s customers are among the leaders in the sector. They are well known for their development of medicines such as the flu vaccine, COVID vaccine, microbe development, cancer medicine, eyedrops, and protein-based medicine.

Boosting Taiwan’s Contract Research and Manufacturing Outsourcing Sector to Meet Growing Demand

We are extremely happy with the solutions and knowledge offered by DKSH. Their industry-leading biopharmaceutical products will greatly contribute to the CDMO industry in Taiwan.

Anonymous, DKSH customer